FrankPLloydJr.MD

PubMed

• 4 citations
  Computer-tailored intervention increases colorectal cancer screening among low-income African Americans in primary care: Results of a randomized trial
  Susan M. Rawl, Shannon M. Christy, Susan M. Perkins, Yan Tong, Connie Krier, Hsiao-Lan Wang, Amelia M. Huang, Esther Laury, Broderick Rhyant, Frank Lloyd, Deanna R. Wi...> ;Preventive Medicine. 2021 Feb 4
• 10 citations
  Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors.
  Sulma I. Mohammed, Odalys J. Torres-Luquis, Elwood K. Walls, Frank Lloyd> ;Molecular Oncology. 2019 May 23
• 54 citations
  Assessing breast tumor margin by multispectral photoacoustic tomography
  Rui Li, Pu Wang, Lu Lan, Frank P. Lloyd Jr., Craig J. Goergen, Shaoxiong Chen, Ji-Xin Cheng> ;Biomedical Optics Express. 2015 Apr 1
• 7 citations
  Automated Blood Sampling and Glucose Sensing in Critical Care Settings
  Kislaya Kunjan, Frank Perry Lloyd> ;Journal of diabetes science and technology. 2008 Mar 1
• 7 citations
  Multifocal papillary-cystic neoplasm of the pancreas.
  Frank P. Lloyd, Jennifer Kang> ;Journal of The National Medical Association. 2003 Dec 1
• 48 citations
  Aspirin inhibits highly invasive prostate cancer cells.
  Frank P. Lloyd, Veronika Slivova, Tatiana Valachovicova, Daniel Sliva> ;International Journal of Oncology. 2003 Nov 1
• 57 citations
  Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells.
  Daniel Sliva, Miroslav Sedlak, Veronika Slivova, Tatiana Valachovicova, Frank P. Lloyd, Nancy W. Y. Ho> ;Journal of Alternative and Complementary Medicine. 2003 Aug 1
• 103 citations
  Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.
  Daniel Sliva, Carlos A. Labarrere, Veronika Slivova, Miroslav Sedlak, Frank P. Lloyd, Nancy W. Y. Ho> ;Biochemical and Biophysical Research Communications. 2002 Nov 8
• 73 citations
  Protein Kinase C Induces Motility of Breast Cancers by Upregulating Secretion of Urokinase-Type Plasminogen Activator through Activation of AP-1 and NF-κB
  Daniel Sliva, Denis English, Denise Lyons, Frank P. Lloyd> ;Biochemical and Biophysical Research Communications. 2002 Jan 11
• Join now to see all

Journal Articles

• Developing and Pretesting a Tailored Interactive Computer Program to Promote Colon Cancer Screening  
  Rawl, S.M., Champion, V.L., Skinner, C.S., Springston, J., Russell, K.M.,Krier, C., Perkins, S., Rhyant, B., Lloyd, F., Willis, D., Doebbeling, D., & Imperiale, T, 4/28/2010
• Exploring the Role of Cancer Fatalism as a Barrier to Colorectal Screening  
  SmithHowell, E.R., Rawl, S.M., Champion, V.L., Skinner, C.S., Springston, J., Krier, C., Russell, K.M., Perkins, S., Rhyant, B., Lloyd, F., Willis, D., Imperiale, T., ..., 4/8/2010
• Automated Blood Sampling and Glucose Sensing in Critical Care Settings  
  Kislaya, K., Lloyd, F, Jr. Diabetes Sci Technol, 1/1/2008
• In Vivo Efficacy in a Prostate Cancer Xenograft Model using a Novel Targeted PI3 Kinase Inhibitor  
  Lloyd F., Durden D, 7/4/2005
• Protein kinase C induces motility of breast cancers by upregulating secretion of urokinasetype plasminogen activator through activation of AP1 and NF  
  Sliva D, English D, Lyons D, Lloyd F Jr, Biochem & Biophys Res Comm, 1/1/2002
• Effect of phosphatidic acid on human breast cancer cells exposed to doxorubicine  
  Lloyd F Jr Sliva D, Harvey K, Mason R, , English D, Cancer Invest, 1/1/2001
• The production of bispecific anticea, antihapten (4aminophthalate) hybridhybridoma  
  Lloyd F, Goldrosen M, JNMA, 1/1/1991
• Localization of monoclonal antibody in a novel nude mouse model of pancreatic cancer  
  Goldrosen M, Loftus F, Biddle W, Paolini N, ED, and Foon, KA, Proceedings of AACR, 1/1/1988
• Join now to see all

Books/Book Chapters

• Managing Cancer: The African American's Guide to Prevention, Diagnosis and Treatment 
  Editors: Rawls G, Lloyd F, Stern H.Hilton Publishing2000

Abstracts/Posters

• Preclinical Efficacy Safety, Pharmacokinetics and Pharmacodynamics of the Targeted PI3 Kinase Inhibitor SF1126
  Garlich J., Lloyd F., Durden D, AACR-NCI-EORTC International Conference on Molecular Targets and Cancer herapeutics: Discovery, Bio, 11/14/2004